vs
卡博特(CBT)与Rollins, Inc.(ROL)财务数据对比。点击上方公司名可切换其他公司
Rollins, Inc.的季度营收约是卡博特的1.1倍($906.4M vs $849.0M),Rollins, Inc.净利率更高(11.9% vs 8.6%,领先3.3%),Rollins, Inc.同比增速更快(10.2% vs -11.1%),Rollins, Inc.自由现金流更多($111.2M vs $57.0M),过去两年Rollins, Inc.的营收复合增速更高(0.8% vs -8.7%)
卡博特公司是总部位于美国马萨诸塞州波士顿的特种化学品和高性能材料企业,业务覆盖全球20多个国家,拥有36座生产工厂、8个研发中心及28个销售办事处,在特种材料领域具备全球领先的技术和服务能力。
Rollins, Inc.是北美知名虫害防治服务商,面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务,覆盖北美、英国等市场,在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
CBT vs ROL — 直观对比
营收规模更大
ROL
是对方的1.1倍
$849.0M
营收增速更快
ROL
高出21.3%
-11.1%
净利率更高
ROL
高出3.3%
8.6%
自由现金流更多
ROL
多$54.2M
$57.0M
两年增速更快
ROL
近两年复合增速
-8.7%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $849.0M | $906.4M |
| 净利润 | $73.0M | $107.8M |
| 毛利率 | 24.9% | — |
| 营业利润率 | 15.2% | 16.1% |
| 净利率 | 8.6% | 11.9% |
| 营收同比 | -11.1% | 10.2% |
| 净利润同比 | -21.5% | 2.5% |
| 每股收益(稀释后) | $1.37 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CBT
ROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $849.0M | $912.9M | ||
| Q3 25 | $899.0M | $1.0B | ||
| Q2 25 | $923.0M | $999.5M | ||
| Q1 25 | $936.0M | $822.5M | ||
| Q4 24 | $955.0M | $832.2M | ||
| Q3 24 | $1.0B | $916.3M | ||
| Q2 24 | $1.0B | $891.9M |
净利润
CBT
ROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $73.0M | $116.4M | ||
| Q3 25 | $43.0M | $163.5M | ||
| Q2 25 | $101.0M | $141.5M | ||
| Q1 25 | $94.0M | $105.2M | ||
| Q4 24 | $93.0M | $105.7M | ||
| Q3 24 | $137.0M | $136.9M | ||
| Q2 24 | $109.0M | $129.4M |
毛利率
CBT
ROL
| Q1 26 | — | — | ||
| Q4 25 | 24.9% | — | ||
| Q3 25 | 24.5% | — | ||
| Q2 25 | 26.4% | — | ||
| Q1 25 | 25.7% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 24.0% | — | ||
| Q2 24 | 25.2% | — |
营业利润率
CBT
ROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | 15.2% | 17.5% | ||
| Q3 25 | 15.2% | 21.9% | ||
| Q2 25 | 18.1% | 19.8% | ||
| Q1 25 | 17.3% | 17.3% | ||
| Q4 24 | 16.2% | 18.1% | ||
| Q3 24 | 15.0% | 20.9% | ||
| Q2 24 | 16.9% | 20.4% |
净利率
CBT
ROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | 8.6% | 12.8% | ||
| Q3 25 | 4.8% | 15.9% | ||
| Q2 25 | 10.9% | 14.2% | ||
| Q1 25 | 10.0% | 12.8% | ||
| Q4 24 | 9.7% | 12.7% | ||
| Q3 24 | 13.7% | 14.9% | ||
| Q2 24 | 10.7% | 14.5% |
每股收益(稀释后)
CBT
ROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | $1.37 | $0.24 | ||
| Q3 25 | $0.80 | $0.34 | ||
| Q2 25 | $1.86 | $0.29 | ||
| Q1 25 | $1.69 | $0.22 | ||
| Q4 24 | $1.67 | $0.22 | ||
| Q3 24 | $2.41 | $0.28 | ||
| Q2 24 | $1.94 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $230.0M | $116.5M |
| 总债务越低越好 | — | $650.6M |
| 股东权益账面价值 | $1.6B | $1.4B |
| 总资产 | $3.8B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.47× |
8季度趋势,按日历期对齐
现金及短期投资
CBT
ROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $230.0M | $100.0M | ||
| Q3 25 | $258.0M | $127.4M | ||
| Q2 25 | $239.0M | $123.0M | ||
| Q1 25 | $213.0M | $201.2M | ||
| Q4 24 | $183.0M | $89.6M | ||
| Q3 24 | $223.0M | $95.3M | ||
| Q2 24 | $197.0M | $106.7M |
总债务
CBT
ROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | — | $486.1M | ||
| Q3 25 | $1.1B | $485.7M | ||
| Q2 25 | — | $485.3M | ||
| Q1 25 | — | $485.5M | ||
| Q4 24 | — | $395.3M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | — | — |
股东权益
CBT
ROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.6B | $1.4B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.4B | $1.4B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.4B | $1.3B | ||
| Q2 24 | $1.3B | $1.2B |
总资产
CBT
ROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $3.8B | $3.1B | ||
| Q3 25 | $3.8B | $3.2B | ||
| Q2 25 | $3.8B | $3.2B | ||
| Q1 25 | $3.8B | $2.9B | ||
| Q4 24 | $3.6B | $2.8B | ||
| Q3 24 | $3.7B | $2.8B | ||
| Q2 24 | $3.6B | $2.8B |
负债/权益比
CBT
ROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | — | 0.35× | ||
| Q3 25 | 0.70× | 0.32× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.36× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | 0.75× | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $126.0M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $57.0M | $111.2M |
| 自由现金流率自由现金流/营收 | 6.7% | 12.3% |
| 资本支出强度资本支出/营收 | 8.1% | 0.8% |
| 现金转化率经营现金流/净利润 | 1.73× | 1.10× |
| 过去12个月自由现金流最近4个季度 | $401.0M | $621.1M |
8季度趋势,按日历期对齐
经营现金流
CBT
ROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $126.0M | $164.7M | ||
| Q3 25 | $219.0M | $191.3M | ||
| Q2 25 | $249.0M | $175.1M | ||
| Q1 25 | $73.0M | $146.9M | ||
| Q4 24 | $124.0M | $188.2M | ||
| Q3 24 | $204.0M | $146.9M | ||
| Q2 24 | $207.0M | $145.1M |
自由现金流
CBT
ROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $57.0M | $159.0M | ||
| Q3 25 | $155.0M | $182.8M | ||
| Q2 25 | $188.0M | $168.0M | ||
| Q1 25 | $1.0M | $140.1M | ||
| Q4 24 | $47.0M | $184.0M | ||
| Q3 24 | $112.0M | $139.4M | ||
| Q2 24 | $155.0M | $136.4M |
自由现金流率
CBT
ROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | 6.7% | 17.4% | ||
| Q3 25 | 17.2% | 17.8% | ||
| Q2 25 | 20.4% | 16.8% | ||
| Q1 25 | 0.1% | 17.0% | ||
| Q4 24 | 4.9% | 22.1% | ||
| Q3 24 | 11.2% | 15.2% | ||
| Q2 24 | 15.3% | 15.3% |
资本支出强度
CBT
ROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 8.1% | 0.6% | ||
| Q3 25 | 7.1% | 0.8% | ||
| Q2 25 | 6.6% | 0.7% | ||
| Q1 25 | 7.7% | 0.8% | ||
| Q4 24 | 8.1% | 0.5% | ||
| Q3 24 | 9.2% | 0.8% | ||
| Q2 24 | 5.1% | 1.0% |
现金转化率
CBT
ROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | 1.73× | 1.41× | ||
| Q3 25 | 5.09× | 1.17× | ||
| Q2 25 | 2.47× | 1.24× | ||
| Q1 25 | 0.78× | 1.40× | ||
| Q4 24 | 1.33× | 1.78× | ||
| Q3 24 | 1.49× | 1.07× | ||
| Q2 24 | 1.90× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBT
| Reinforcement Materials | $520.0M | 61% |
| Performance Chemicals | $300.0M | 35% |
| Shipping And Handling | $25.0M | 3% |
| Other Products And Services | $4.0M | 0% |
ROL
暂无分部数据